Physician profile
William Van Rice
NPI 1902840606
$45,925.83
in general payments reported to CMS, 2019-2025
7 companies · $8,631 in 2025
The $8,631 reported for 2025 was more than what 94% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2021: $10K · 2022: $14K · 2023: $1,796 · 2024: $11K · 2025: $8,631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Travel and Lodging: $2,193 · Food and Beverage: $1,464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,855.36 |
| Travel and Lodging | $2,193.33 |
| Food and Beverage | $1,463.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $35,378.62 | 2021-2024 | Gore Seamguard Bioabsorbable Staple Line Reinforce, Seamguard, Seamguard Staple Line Reinforcement |
| Ethicon US, LLC | $7,473.79 | 2019-2025 | Enseal, Echelon Flex, Echelon; Endopath |
| Medical Device Business Services, INC. | $2,582.66 | 2023-2025 | |
| Medtronic, INC. | $285.64 | 2023 | Signia |
| Abiomed | $128.85 | 2023 | Impella |
| Intuitive Surgical, INC. | $58.97 | 2025 | |
| Ambu INC. | $17.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Rice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.